EUVIMEDEUVIMED entdecken
Crossref

Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF-κB p65 signaling pathway and MMP9

Lijuan Liu, Huiling Zhang, Xinran Tang, Mengge Zhang, Yayun Wu, Ya Zhao, Chuanjian Lu, Ruizhi Zhao

International Immunopharmacology · 2024-05 · 133 · 112082

DOI: 10.1016/j.intimp.2024.112082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-05. Verfasst von Lijuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China. Hauptthemen laut MEDLINE: Iridoids, Matrix Metalloproteinase 9, Psoriasis, Signal Transduction. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is an incurable immune-mediated disease affecting the skin or the joints. There are continuing studies on drugs for psoriasis prevention and treatment. This research found that Geniposide (GE) significantly thinned IMQ mice's skin lesions, reduced the scales, and lowered the presence of inflammatory cells in the pathology in a dose-dependent manner. GE inhibited IL-23, IL-22, IL-17A, IL-12, IL-6, and TNF-α levels in psoriatic mice serum. AKT1, TNF, TLR4, MMP9, MAPK3, and EGFR were selected as the top 6 targets of GE against psoriasis via network pharmacology, and GE-TLR4 has the most robust docking score value by molecular docking. Taken together, GE significantly inhibited TLR4 and MMP9 protein expression and influenced MyD88/NF-κB p65 signaling pathway. Finally, TLR4 was verified as the critical target of GE, which engaged in immunomodulatory activities and reduced MMP9 production in LPS and TAK-242-induced HaCaT cells. GE had a medium affinity for TLR4, and the KD value was 1.06 × 10-5 M. GE is an effective treatment and preventative strategy for psoriasis since it impacts TLR4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridoidsMatrix Metalloproteinase 9PsoriasisSignal TransductionAnimalsHumansMaleMiceAnti-Inflammatory AgentsCell LineCytokinesDisease Models, AnimalHaCaT CellsMolecular Docking SimulationMyeloid Differentiation Factor 88SkinToll-Like Receptor 4Transcription Factor RelA

Stichwörter der Autor:innen

GeniposideMMP9Molecular dockingNetwork pharmacologyPsoriasisTLR4

Substanzen

Anti-Inflammatory AgentsCytokinesgeniposideIridoidsMatrix Metalloproteinase 9Mmp9 protein, mouseMyd88 protein, mouseMyeloid Differentiation Factor 88Tlr4 protein, mouseToll-Like Receptor 4

Autor:innen und Institutionen

  • The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China.
  • The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoling Province 110016, Chi…
  • The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndro…
  • The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital o…

Zitieren

APA

Liu, L., Zhang, H., Tang, X., Zhang, M., Wu, Y., Zhao, Y., Lu, C., & Zhao, R. (2024). Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF-κB p65 signaling pathway and MMP9. International Immunopharmacology, 133, 112082. https://doi.org/10.1016/j.intimp.2024.112082

Vancouver

Liu L, Zhang H, Tang X, Zhang M, Wu Y, Zhao Y, et al. Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF-κB p65 signaling pathway and MMP9. International Immunopharmacology. 2024;133:112082. doi:10.1016/j.intimp.2024.112082

BibTeX
@article{Liu2024,
  author = {Liu, Lijuan and Zhang, Huiling and Tang, Xinran and Zhang, Mengge and Wu, Yayun and Zhao, Ya and Lu, Chuanjian and Zhao, Ruizhi},
  title = {Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF-κB p65 signaling pathway and MMP9},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {133},
  pages = {112082},
  doi = {10.1016/j.intimp.2024.112082}
}
Kostenlos starten →